Private Equity Investors

Private Equity Investors, Inc. is a private equity and venture capital firm specializing in fund of funds and secondary acquisitions in secondary indirect investments. Within direct, it prefers to invest in mature and late ventures. For fund of funds investments, it seeks to invest in venture capital, growth equity, private equity, leveraged buyout & mezzanine funds and manages funds-of-funds that invest in venture capital, growth equity, and buyout funds at the time of their origination. It seeks to purchase limited partnership interests, portfolios of direct private holdings, fund restructurings, financial institutions or corporate spin-outs, and all the assets of a fund or fund of funds. Within the secondary transactions that the firm makes to general partners of mature funds and fund of funds, it provides fund or fund of funds wind down, asset purchase, tender offers, and restructuring solutions. Within the secondary transactions, the firm provides cash purchase, purchase of non strategic holdings, and restructuring to corporate venture programs. The firm also provides liquidity to limited partners of private equity funds and to investors with portfolios of direct holdings. It prefers to invest in logistics and retail, communications, and healthcare. It invests in funds investing in broadly diversified sectors including biotechnology, consumer or retail, financial, healthcare, industrial, materials, media or communications, and technology. It seeks investments across the United States and overseas while investing in other funds. It seeks to make investments in interest with asset value between $1 million and $25 million. The firm typically acquires limited partnership interests in transactions with values ranging between $1 million and $100 million, but typically looks at transactions with less than $50 million in value and $30 million in net asset value. It invests between $1 million & $30 million. Private Equity Investors, Inc. was founded in 1992 and is based in New York, New York with additional offices in Chicago, Illinois; San Francisco, California; and Tokyo, Japan.

1 past transactions

AcuFocus

Private Placement in 2018
Acufocus, Inc., a medical device company, engages in the research, development, and marketing of solutions for the treatment of presbyopia. The company develops KAMRA, a corner inlay for the treatment of near vision loss that allows patients to see near and intermediate objects clearly; and AcuTarget, a system that is used to guide surgeons on surgical placement of the KAMRA. Its products are used in eye care centers in the United States, Asia, and Europe. Acufocus, Inc. was founded in 2001 and is based in Irvine, California.